Regulus Therapeutics Statistics
Total Valuation
IIPR has a market cap or net worth of $1.29 billion. The enterprise value is $1.48 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
IIPR has 28.02 million shares outstanding. The number of shares has increased by 0.87% in one year.
Current Share Class | 28.02M |
Shares Outstanding | 28.02M |
Shares Change (YoY) | +0.87% |
Shares Change (QoQ) | +0.12% |
Owned by Insiders (%) | 1.62% |
Owned by Institutions (%) | 71.19% |
Float | 27.56M |
Valuation Ratios
The trailing PE ratio is 9.94 and the forward PE ratio is 12.39.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | 7.80 |
PE Ratio | 9.94 |
Forward PE | 12.39 |
PS Ratio | 4.51 |
Forward PS | 4.64 |
PB Ratio | 0.70 |
P/TBV Ratio | 0.70 |
P/FCF Ratio | n/a |
P/OCF Ratio | 5.73 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 11.12 |
EV / Sales | 5.15 |
EV / EBITDA | 6.61 |
EV / EBIT | 9.80 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.15.
Current Ratio | 1.89 |
Quick Ratio | 1.54 |
Debt / Equity | 0.15 |
Debt / EBITDA | 1.29 |
Debt / FCF | n/a |
Interest Coverage | 8.44 |
Financial Efficiency
Return on equity (ROE) is 7.18% and return on invested capital (ROIC) is 4.28%.
Return on Equity (ROE) | 7.18% |
Return on Assets (ROA) | 4.03% |
Return on Invested Capital (ROIC) | 4.28% |
Return on Capital Employed (ROCE) | 6.75% |
Revenue Per Employee | $13.09M |
Profits Per Employee | $6.06M |
Employee Count | 22 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.77% in the last 52 weeks. The beta is 1.68, so IIPR's price volatility has been higher than the market average.
Beta (5Y) | 1.68 |
52-Week Price Change | -59.77% |
50-Day Moving Average | 55.02 |
200-Day Moving Average | 72.46 |
Relative Strength Index (RSI) | 22.53 |
Average Volume (20 Days) | 312,100 |
Short Selling Information
The latest short interest is 1.77 million, so 6.32% of the outstanding shares have been sold short.
Short Interest | 1.77M |
Short Previous Month | 1.79M |
Short % of Shares Out | 6.32% |
Short % of Float | 6.43% |
Short Ratio (days to cover) | 6.27 |
Income Statement
In the last 12 months, IIPR had revenue of $287.88 million and earned $133.28 million in profits. Earnings per share was $4.64.
Revenue | 287.88M |
Gross Profit | 258.74M |
Operating Income | 151.14M |
Pretax Income | 164.65M |
Net Income | 133.28M |
EBITDA | 224.22M |
EBIT | 151.14M |
Earnings Per Share (EPS) | $4.64 |
Full Income Statement Balance Sheet
The company has $99.67 million in cash and $289.86 million in debt, giving a net cash position of -$190.20 million or -$6.79 per share.
Cash & Cash Equivalents | 99.67M |
Total Debt | 289.86M |
Net Cash | -190.20M |
Net Cash Per Share | -$6.79 |
Equity (Book Value) | 1.88B |
Book Value Per Share | 65.80 |
Working Capital | 57.62M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 225.37M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 89.88%, with operating and profit margins of 52.50% and 47.71%.
Gross Margin | 89.88% |
Operating Margin | 52.50% |
Pretax Margin | 47.71% |
Profit Margin | 47.71% |
EBITDA Margin | 77.88% |
EBIT Margin | 52.50% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $7.60, which amounts to a dividend yield of 16.49%.
Dividend Per Share | $7.60 |
Dividend Yield | 16.49% |
Dividend Growth (YoY) | 3.54% |
Years of Dividend Growth | 8 |
Payout Ratio | 146.17% |
Buyback Yield | -0.87% |
Shareholder Yield | 15.61% |
Earnings Yield | 10.32% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for IIPR is $88.75, which is 92.52% higher than the current price. The consensus rating is "Hold".
Price Target | $88.75 |
Price Target Difference | 92.52% |
Analyst Consensus | Hold |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |